Matthew P. Young, EVP & CFO at Jazz Pharmaceuticals plc (JAZZ), sold 6,084 shares at $137.91 ($790K) on 2019-02-27, disclosed to the SEC on 2019-02-27.
Open-market sale of $790k JAZZ by EVP & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $126.25 | 1,218 | $154K | 19.5% |
| 2 | $125.93 | 1,032 | $130K | 16.5% |
| 3 | $125.93 | 1,032 | $130K | 16.5% |
| 4 | $127.76 | 1,034 | $132K | 16.7% |
| 5 | $137.91 | 884 | $122K | 15.4% |
| 6 | $137.91 | 884 |
| $122K |
| 15.4% |
| Total | $129.79 avg | 6,084 | $790K | 100% |
| Filing → |
| JAZZ | SELL | 2018-10-17 | $221K | — | Filing → |
| JAZZ | SELL | 2018-09-19 | $228K | — | Filing → |
| JAZZ | SELL | 2018-08-16 | $246K | — | Filing → |